Solid Biosciences Inc. — Director's Dealing 2018

Jan 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-01-30

Reporting Person: Shah Rajeev M. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-30	Common Stock	P	1000000	$16.00	Acquired	2689444	Indirect

Footnotes

F1: These securities include 808,990 shares held by RA Capital Healthcare Fund, L.P. (the "Fund") and 191,010 shares held in an account owned by a separately managed account (the "Account").

F2: Represents 2,177,971 shares of Common Stock held by the Fund and 511,473 shares of Common Stock held in the Account.

F3: RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Mr. Shah is a member of the Adviser. Mr. Shah has no pecuniary interest in the reported securities held in the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by the Fund except to the extent of his pecuniary interest therein.